Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Myriam Calle RubioPulmonology Department, Hospital Clínico San Carlos, Department of Medicine, School of Medicine, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0002-3890-2742
Pilar Cebollero RivasRespiratory Department, University Hospital of Navarra (HUN), 31008 Pamplona, Spain.ORCID 0000-0002-6796-5603
Cristóbal EstebanRespiratory Department, BioCruces-Bizkaia Health Research Institute, Hospital Universitario Galdakao-Usansolo, Health Services Research on Chronic Patients Network (REDISSEC), Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 48960 Galdakao, Spain.ORCID 0000-0003-1199-9166
Antonia Fuster GomilaRespiratory Medicine Department, Hospital Universitario Son Llàtzer, 07198 Palma de Mallorca, Spain.
José Alfonso García GuerraRespiratory Medicine Service, Hospital La Mancha Centro de Alcázar de San Juan, 13600 Ciudad Real, Spain.ORCID 0000-0001-6355-2548
Jesús R Hernández HernándezRespiratory Department, Ávila Health Care Complex, 05071 Ávila, Spain.
Jessica Sara Lozada BonillaConsorci Hospital General Universitari, 46014 Valencia, Spain.ORCID 0009-0006-3629-6634
Juan Marco Figueira-GonçalvesUniversity Hospital Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0002-1564-1172
Eduardo MarquezCIBER de Enfermedades Respiratorias (CIBERES), 28040 Madrid, Spain.ORCID 0000-0001-5715-7613
José Javier Martínez GarceranRespiratory Diseases Department, Santa Lucia University Hospital, 30202 Cartagena, Spain.ORCID 0000-0002-7676-9372
Javier de Miguel-DíezRespiratory Department, Gregorio Marañón General University Hospital, Faculty of Medicine, Gregorio Marañón Biomedical Research Institute, Complutense University of Madrid, 28007 Madrid, Spain.ORCID 0000-0003-4543-573X
Ana Pando-SandovalRespiratory Medicine Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Juan A RiescoCIBER de Enfermedades Respiratorias (CIBERES), 28040 Madrid, Spain.ORCID 0000-0002-7418-0759
Rafael Sánchez-Del HoyoResearch Methodological Support Unit and Preventive Department, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.ORCID 0000-0002-3462-4183
Juan Luis Rodríguez HermosaPulmonology Department, Hospital Clínico San Carlos, Department of Medicine, School of Medicine, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-0552-2484
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Chronic obstructive pulmonary disease (COPD) represents one of the most frequent causes of hospital readmissions and in-hospital mortality. One in five patients requires readmission within 30 days of discharge following an admission for exacerbation. These 'early readmissions' increase morbidity and mortality, as patients often do not recover their baseline lung function. The identification of factors associated with increased risk has been a major focus of research in recent years. Studies describe patient-related predictors, although some studies also suggest that better-resourced centres provide superior care.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project. · full record | OpenQuestion